A Phase 3 Prospective, Randomized, Double-blinded, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of Rebiotix RBX2660 (microbiota suspension) for the Prevention of Recurrent Clostridium difficile Infection
Recently Completed:
A Multi-center, Randomized, Double-blind Study to Compare the Efficacy and Safety of Cadazolid versus Vancomycin in subjects with Clostridium difficile-associated diarrhea (CDAD)
An Open-label Efficacy and Safety Assessment of Rebiotix RBX2660 (microbiota suspension) for the Treatment of Recurrent Clostridium difficile Infection